Navigation path

Left navigation

Additional tools

The EU contribution to the Global Fund to fight AIDS, Tuberculosis and Malaria

European Commission - MEMO/10/470   04/10/2010

Other available languages: none

MEMO/10/470

Brussels, 4 October 2010

The EU contribution to the Global Fund to fight AIDS, Tuberculosis and Malaria

On Tuesday, 5 October, Andris Piebalgs, the European Commissioner for Development will participate in the Third Voluntary Replenishment Pledging Conference of the Global Fund to fight AIDS, Tuberculosis and Malaria (GFATM) in New York. The conference commences on 4 October with a general debate on resources mobilisation activities, comprehensive funding policy review and statements from participants. The pledging session of the Conference will be chaired by Ban Ki Moon, UN Secretary General, while Richard Manning, former Head of OECD Development Assistance Committee (DAC), will be the operative vice-chair.

Confronting HIV/AIDS, malaria and tuberculosis remains a major challenge for many developing countries in the effort to achieve health-related Millennium Development Goals (MDGs) by 2015. The response to HIV/AIDS and other poverty diseases such as malaria and tuberculosis is an important part of the EU development agenda as outlined in the European Consensus on Development and in the Joint Statement signed on 20 December 2005, which states that the Commission will support the Global Fund to fight AIDS, Tuberculosis and Malaria (GFATM).

The EU contributions to the Global Fund to fight AIDS, Tuberculosis and Malaria

The Commission and the EU Member States have been supporting strongly the Global Fund since its creation. See the table below for figures:

DONORS

 

TOTAL PLEDGES TO DATE

 

AMOUNT PLEDGED

EQUIVALENT IN USD

PERIOD OF PLEDGE

TOTAL PAID TO DATE (USD)

Countries

Australia2

 

AUD

210.000.000

171.027.145

2004-2010

171.027.145

Belgium

 

EUR

93.333.222

118.775.977

2001-2010

118.961.280

Denmark

 

DKK

1.236.600.000

209.357.495

2002-2010

209.357.495

European Commission

 

EUR

1.072.500.000

1.399.874.546

2001-2013

1.204.218.118

Finland

 

EUR

15.000.000

20.176.700

2006-2009

20.176.700

France

 

EUR

1.825.000.000

2.425.121.928

2002-2010

2.196.856.097

Germany

 

EUR

923.500.000

1.247.695.504

2002-2010

1.186.389.823

Greece

 

EUR

1.600.000

2.150.085

2005, 2007, 2008

2.150.085

Hungary

 

USD

55.000

55.000

2004-06, 2008

55.000

Ireland

 

EUR

170.000.000

220.471.439

2002-2010

160.535.353

Italy

 

USD

200.000.000

200.000.000

2002-2003

215.160.273

 

EUR

850.000.000

1.132.238.407

2004-2010

793.100.600

Latvia

 

USD

10.000

10.000

2008

10.000

Luxembourg3

 

EUR

18.550.000

24.037.270

2002-2010

24.037.270

Netherlands4

 

EUR

485.000.000

636.613.874

2002-2010

519.220.017

Poland

 

USD

150.000

150.000

2003-06, 2008

150.000

Portugal2

 

USD

15.500.000

15.500.000

2003-2010

13.000.000

Romania

 

EUR

475.000

675.017

2007-2010

609.798

Slovenia

 

SIT

5.400.000

28.080

2004-2006

28.080

 

EUR

110.000

157.229

2007-2008

157.229

Spain

 

USD

764.547.085

764.547.085

2003-05, 2007-10

518.751.614

 

EUR

50.000.000

63.900.000

2006

63.900.000

Gen.Catalunya/ Spain

 

EUR

5.500.000

7.898.369

2005-2008

7.898.369

Sweden7

 

SEK

3.856.000.000

537.226.451

2002-2010

468.040.397

United Kingdom8

 

GBP

1.359.000.000

2.227.376.561

2001-2015

1.179.417.200

TOTAL EU

 

 

 

11.425.064.163

 

9.073.207.945

Total public support

 

 

 

21.000.660.740

 

16.232.481.898

Total private support

839.846.099

 

934.062.801

Grand Total

21.840.506.839

 

17.166.544.699

Source: The Global Fund website (http://www.theglobalfund.org/en/pledges/)

Results attributable to the EU contribution to the GFATM (2002-2009)

The percentage of the overall EU contribution to the GFATM it is around 50-55%. On the bases, the estimated results (in terms of outputs covering 144 countries) attributable to the EC and EU contribution to the GFATM are the following:

GFATM

EU (50.32%)

EC (7.4%)

Nr of people with advanced HIV infection receiving antiretroviral combination therapy

  • 2.500.000 people

  • 1.900.000 people (76%) in Sub-Saharan Africa.

  • 1.258.000 people

  • 956.000 people (76%) in Sub-Saharan Africa

  • 185.000 people

  • 140.600 people (76%) in Sub-Saharan Africa

Nr of people smear positive tuberculosis under DOTS (the internationally agreed strategy for Tuberculosis control ant treatment)

  • 6.000.000 people

  • 1.400.000 people (23%) in Sub-Saharan Africa people

  • 3.019.200 people

  • 694.400 people (23%) in Sub-Saharan Africa

  • 444.000 people

  • 102.120 people (23%) in Sub-Saharan Africa

Nr of insecticide treated nets distributed

  • 104.000.000 nets

  • 72.000.000 nets (69%) in Sub-Saharan Africa

  • 52.332.800 people

  • 36.109.632 nets (69%) in Sub-Saharan Africa

  • 7.696.000 people

  • 5.310.240 nets (69%) in Sub-Saharan Africa

Nr of HIV-positive pregnant women with treatment to prevent mother to child transmission of HIV

  • 790.000 women

  • 674.100 women (85%) in Sub-Saharan Africa

  • 397.528 women

  • 337. 898 women (85%) in Sub-Saharan Africa

  • 58.460 women

  • 49.844 women (85%) in Sub-Saharan Africa

Nr of lives saved

  • 4.900.000 lives

  • 2.465.680 lives

  • 362.000 lives

Policy background

HIV/AIDS, malaria and tuberculosis severely undermine overall human and social development efforts. In 2000, the Commission redefined its role and accelerated its response to fight HIV/AIDS, malaria and tuberculosis in a coherent and comprehensive framework. Based on this framework, in 2001 the Commission adopted a Programme for Action to improve the effectiveness of existing initiatives targeting the major communicable diseases and poverty reduction, make pharmaceuticals more affordable and support research and development on global public goods to confront these diseases.

The Commission policy on HIV/AIDS, malaria and tuberculosis is further spelled out in the Commission communication adopted in October 2004 A coherent European policy framework for external action to confront HIV/AIDS, malaria and tuberculosis. In April 2005, the Commission adopted a new Programme for Action, A European programme for action to confront HIV/AIDS, malaria and tuberculosis through external action 2007-2011, which proposes a series of actions at both country and global levels. The actions at country level include capacity building, enhancing human resources capacity to mitigate brain drain, broad cooperation between stakeholders, investing in social services and surveillance, monitoring health outcomes, and strengthening local production capacity for pharmaceutical products. Proposed actions at global level cover five areas: affordable pharmaceutical products, strengthening regulatory capacity in developing countries; developing new tools and interventions, strengthening partnerships with multilateral agencies and other institutions, and maintaining a strong European voice at G8 and EU summits. A major objective of the programme is to increase efforts to scale up interventions that have shown results.


Side Bar

My account

Manage your searches and email notifications


Help us improve our website